1. Home
  2. FORD vs COGT Comparison

FORD vs COGT Comparison

Compare FORD & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORD
  • COGT
  • Stock Information
  • Founded
  • FORD 1961
  • COGT 2014
  • Country
  • FORD United States
  • COGT United States
  • Employees
  • FORD N/A
  • COGT N/A
  • Industry
  • FORD Plastic Products
  • COGT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORD Industrials
  • COGT Health Care
  • Exchange
  • FORD Nasdaq
  • COGT Nasdaq
  • Market Cap
  • FORD 2.1B
  • COGT 2.3B
  • IPO Year
  • FORD 1995
  • COGT 2018
  • Fundamental
  • Price
  • FORD $17.52
  • COGT $14.82
  • Analyst Decision
  • FORD
  • COGT Strong Buy
  • Analyst Count
  • FORD 0
  • COGT 12
  • Target Price
  • FORD N/A
  • COGT $22.00
  • AVG Volume (30 Days)
  • FORD 469.4K
  • COGT 2.3M
  • Earning Date
  • FORD 08-14-2025
  • COGT 11-11-2025
  • Dividend Yield
  • FORD N/A
  • COGT N/A
  • EPS Growth
  • FORD N/A
  • COGT N/A
  • EPS
  • FORD N/A
  • COGT N/A
  • Revenue
  • FORD $25,188,450.00
  • COGT N/A
  • Revenue This Year
  • FORD N/A
  • COGT N/A
  • Revenue Next Year
  • FORD N/A
  • COGT N/A
  • P/E Ratio
  • FORD N/A
  • COGT N/A
  • Revenue Growth
  • FORD 6.11
  • COGT N/A
  • 52 Week Low
  • FORD $3.32
  • COGT $3.72
  • 52 Week High
  • FORD $46.00
  • COGT $17.15
  • Technical
  • Relative Strength Index (RSI)
  • FORD 39.14
  • COGT 50.05
  • Support Level
  • FORD $20.22
  • COGT $14.20
  • Resistance Level
  • FORD $25.50
  • COGT $17.15
  • Average True Range (ATR)
  • FORD 2.37
  • COGT 0.87
  • MACD
  • FORD -1.13
  • COGT -0.21
  • Stochastic Oscillator
  • FORD 10.29
  • COGT 23.56

About FORD Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: